V010-6869 Screening compound: N-(3-butoxypropyl)-4-[5-(4-methoxyphenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzamide

V010-6869 Screening compound: N-(3-butoxypropyl)-4-[5-(4-methoxyphenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzamide
V010-6869 Screening compound: N-(3-butoxypropyl)-4-[5-(4-methoxyphenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-6869
N-(3-butoxypropyl)-4-[5-(4-methoxyphenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-6869

Molecular Formula

C28H33N5O4 (C28 H33 N5 O4)

Compound Name

N-(3-butoxypropyl)-4-[5-(4-methoxyphenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzamide

IUPAC name

N-(3-butoxypropyl)-4-[5-(4-methoxyphenyl)-4-methyl-3-(5-methyl-134-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzamide

SMILES

CCCCOCCCNC(c(cc1)ccc1-n(c(-c(cc1)ccc1OC)c1C)nc1-c1nnc(C)o1)=O

InChI

InChI=1S/C28H33N5O4/c1-5-6-17-36-18-7-16-29-27(34)22-8-12-23(13-9-22)33-26(21-10-14-24(35-4)15-11-21)19(2)25(32-33)28-31-30-20(3)37-28/h8-15H,5-7,16-18H2,1-4H3,(H,29,34)

InChI Key

NYWBKLDDMNZLIO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19948295

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

503.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.910

Distribution Coefficient, logD

3.910

Water Solubility, LogSw

-3.96

Polar Surface Area

83.693

Acid Dissociation Constant (pKa)

14.01

Base Dissociation Constant (pKb)

0.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.70

V010-6869 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V010-6869 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-6869?
Check Price and Availability of V010-6869, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-6869 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-6869
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-6869
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-6869 available by request